Cargando…

Liver injury in remdesivir-treated COVID-19 patients

Detalles Bibliográficos
Autores principales:	Zampino, Rosa, Mele, Ferruccio, Florio, Letizia Lucia, Bertolino, Lorenzo, Andini, Roberto, Galdo, Maria, De Rosa, Rosanna, Corcione, Antonio, Durante-Mangoni, Emanuele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386240/ https://www.ncbi.nlm.nih.gov/pubmed/32725454 http://dx.doi.org/10.1007/s12072-020-10077-3

Ejemplares similares

Early experience with remdesivir in SARS-CoV-2 pneumonia
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2020)

Guillain-Barré syndrome as clinical presentation of a recently acquired hepatitis C
por: Boccia, Filomena, et al.
Publicado: (2023)

Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis
por: Zampino, Rosa, et al.
Publicado: (2021)

Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review
por: Ramadan, Mohammad Said, et al.
Publicado: (2021)

Infective endocarditis involving MitraClip(©) devices: a systematic literature review
por: Bertolino, Lorenzo, et al.
Publicado: (2023)

Low rate of severe acute respiratory syndrome coronavirus 2 spread among health-care personnel using ordinary personal protection equipment in a medium-incidence setting
por: Durante-Mangoni, E., et al.
Publicado: (2020)

Incidence, Risk Factors and Clinical Implications of Glucose Metabolic Changes after Heart Transplant
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2022)

Long-Term Outcome of Infective Endocarditis Involving Cardiac Implantable Electronic Devices: Impact of Comorbidities and Lead Extraction
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2022)

Risk Factors and Outcome of Multidrug-Resistant Infections after Heart Transplant: A Contemporary Single Center Experience
por: Karruli, Arta, et al.
Publicado: (2021)

Clinical Characteristics and Outcome of MDR/XDR Bacterial Infections in a Neuromuscular Semi-Intensive/Sub-Intensive Care Unit
por: Karruli, Arta, et al.
Publicado: (2022)

Dissecting the correlates of N-terminal prohormone brain natriuretic peptide in acute infective endocarditis
por: Bertolino, Lorenzo, et al.
Publicado: (2022)

Cardiac complications during the active phase of COVID-19: review of the current evidence
por: Ramadan, Mohammad Said, et al.
Publicado: (2021)

Clinical Significance and Prognostic Value of Hemostasis Parameters in 337 Patients with Acute Infective Endocarditis
por: Zampino, Rosa, et al.
Publicado: (2021)

Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment
por: Iossa, Domenico, et al.
Publicado: (2021)

Does this patient have COVID-19? A practical guide for the internist
por: Bertolino, Lorenzo, et al.
Publicado: (2020)

Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis
por: Zampino, Rosa, et al.
Publicado: (2022)

Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective
por: Ramadan, Mohammad Said, et al.
Publicado: (2021)

Safety and Efficacy of Direct Antiviral Agents for Hepatitis C in Patients with Malignancies Other Than Liver Cancer: A Case Series
por: Patauner, Fabian, et al.
Publicado: (2022)

Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
por: Ramadan, Mohammad Said, et al.
Publicado: (2022)

Clinical significance of hyperhomocysteinemia in infective endocarditis: A case–control study
por: Iossa, Domenico, et al.
Publicado: (2016)

Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comprehensive Review of Existing and Emerging Therapies
por: Unar, Ahsanullah, et al.
Publicado: (2023)

Pathophysiology of Disseminated Intravascular Coagulation in Sepsis: A Clinically Focused Overview
por: Unar, Ahsanullah, et al.
Publicado: (2023)

Emerging Treatment Options for Multi-Drug-Resistant Bacterial Infections
por: Giurazza, Roberto, et al.
Publicado: (2021)

Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis
por: Maraolo, Alberto Enrico, et al.
Publicado: (2022)

Effect of a Cooperation Strategy between Primary Care Physicians and Hospital Liver Units on HBV Care in Campania, Italy
por: Zampino, Rosa, et al.
Publicado: (2018)

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)
por: Pallotto, Carlo, et al.
Publicado: (2021)

Effects of Direct-Acting Antiviral Agents on the Mental Health of Patients with Chronic Hepatitis C: A Prospective Observational Study
por: Fabrazzo, Michele, et al.
Publicado: (2020)

Remdesivir in Breastfeeding
por: Sadati, Elham, et al.
Publicado: (2022)

Re: Remdesivir for the treatment of COVID-19 by Lee et al.
por: Beccacece, Alessia, et al.
Publicado: (2023)

Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver
por: Yan, Victoria C., et al.
Publicado: (2021)

Remdesivir in moderate to severe COVID-19: A matter of time?
por: Bonazzetti, Cecilia, et al.
Publicado: (2021)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Anaphylaxis Due to Remdesivir
por: Hopkins, Brian J., et al.
Publicado: (2021)

Liver and kidney function in patients with Covid‐19 treated with remdesivir
por: van Laar, Sylvia A., et al.
Publicado: (2021)

Successful management of remdesivir extravasation
por: Conde-Estévez, David, et al.
Publicado: (2022)

A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma
por: Iaboni, Aled, et al.
Publicado: (2021)

Status of Remdesivir: Not Yet Beyond Question!
por: Chatterjee, Saptarshi
Publicado: (2021)

Reply to Yan and Muller, “Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver”
por: Murakami, Eisuke, et al.
Publicado: (2021)

Response to: Status of Remdesivir: Not Yet Beyond Question!
por: Saha, Abinit, et al.
Publicado: (2021)

Pulmonary administration of remdesivir in the treatment of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5gfabefiuuvbhurtc73afqmfbi